Recordati's revenue rises 5% in Q1 despite FX impact
April 29 (Reuters) - Italian pharmaceutical company Recordati RECI.MI reported on Wednesday a 4.9% rise in its first-quarter net revenue to 713.4 million euros ($834.7 million). The company said its revenue was hit by an adverse impact from foreign exchange (FX) of 29.1 million euros. Recordati will post its full Q1 financial results on May 12, 2026. ($1 = 0.8547 euros) (Reporting by Mirko Miorelli) ((Mirko.miorelli@thomsonreuters.com))
Recent news on Recordati Industria Chimica e Farmaceutica
See all newsItaly - Factors to watch on October 26
Deals of the day-Mergers and acquisitions
Brief: Recordati Says 66.67% Threshold Condition In Recordati Fulfilled
Brief: Recordati - CVC Capital Partners IX Aggregator Holds 19,189,219 Recordati Shares, 9.18% Of Share Capital
CVC, GBL hold 74.3% of Italian drugmaker Recordati at end of takeover offer period